期刊文献+

O^6-甲基鸟嘌呤-DNA-甲基转移酶在子宫颈癌中的表达及临床意义 被引量:1

Expression and clinical significance of O^6-methylguanine DNA methyltransferase in cervical cancer tissues
下载PDF
导出
摘要 目的探讨O6-甲基鸟嘌呤-DNA-甲基转移酶(MGMT)在子宫颈癌组织中表达情况及其临床意义。方法采用免疫组织化学染色方法检测子宫颈癌组织中MGMT的表达。结果 60例子宫颈癌组织中MGMT的阳性表达率为93.33%,显著高于14例对照正常宫颈组织中阳性率42.8%,(P<0.05);子宫颈癌患者中,Ⅰ期与Ⅱ期的MGMT阳性率分别为100%、95.83%,显著高于Ⅲ-Ⅳ期的阳性率62.5%(P<0.01)。结论 MGMT的表达水平与宫颈组织癌变发展的进程相关,其在宫颈癌组织的高表达可为宫颈癌的诊断提供重要依据。 Objective To investigate the expression of O6-methylguanine DNA methyltransferase (MGMT) and its clinical sig-nificance in cervical cancer. Methods The expression of MGMT in cervical cancer tissues was detected by immunohistochemistry staining method. Results The expression of MGMT in cervical carcinoma group was higher than that in normal cervical tissues, and the positive rates were 93.33% and 42.8% respectively (P〈0.05). In PhaseⅠandⅡcervical cancer, the expression rates of MGMT (100%and 95.83%respectively) were significantly higher than that in Phase Ⅲ-Ⅳcervical cancer (62.5%, P〈0.01). Conclusion MGMT expression level associates with the development process of cervical cancer, its high expression in cervical cancer tissue plays an important role in the diagnosis of cervical cancer.
出处 《实验与检验医学》 CAS 2014年第6期680-682,共3页 Experimental and Laboratory Medicine
基金 江西省卫生厅科技计划项目(No.20092025 20092026)
关键词 O6-甲基鸟嘌呤-DNA-甲基转移酶 子宫颈癌 免疫组织化学染色 O6-methylguanine DNA methyltransferase,Cervical cancer Immunohistochemistry staining
  • 相关文献

参考文献12

  • 1方丽娟,袁水斌,王刚,魏小文.江西地区人乳头瘤病毒感染分型检测的研究[J].实验与检验医学,2013,31(2):181-182. 被引量:14
  • 2Matsukura S, Soejima H, Nakagawachi T, et al. CpG methyation of MGMT and hMLH1 promoter in hepatoceuar carcinoma associated with hepatitis vira infection [J]. Br Cancer,2003,88(4):521-529.
  • 3Reese JS, Allay E, Gerson SL. Over expression of human 06 alkyl- guanine DNA alkyltran sferase (AGT) prevents MNU induced lym- phomas in p53 deficient mice [J].Oncogene, 2001,20 (38):5258- 5263.
  • 4Virmani AK, Muller C, Rathi A, et al. Aberrant methylation during cervical carcinogenesis[J].Clin Cancer Res,2001,7(3):584-589.
  • 5Svrcek M, Buhard O, Colas C,et al. Methylation tolerance due to an 06-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mis- match repair-deficient colorectal cancers [J]. Gut,2010,59 (11): 1516-26.
  • 6Shen L, Kondo Y, Rosner GL,et al. MGMT promoter methylation and field defect in sporadic colorectal cancer[J]. J Natl Cancer In- st, 2005,97(18): 1330-8.
  • 7Rimel B J, Huettner P, Powell MA,et al. Absence of MGMT pro- moter methylation in endometrial cancer [J]. Gynecol Oncol, 2009,112( 1 ):224-228.
  • 8Matsukura S, Soejima H,Nakagawachi T, et al. CpG methylation of MGMT and hMLHI promoter in hepatocellular carcinoma associ- ated with hepatitis viral infection [J].Br Cancer,2003,88 (4):521- 529.
  • 9阿比达.阿布都卡德尔,纳菲沙.卡德尔,阿布力孜.阿布杜拉,丁岩.维、汉族妇女宫颈病变中抑癌基因DAPK1、MGMT表达及其意义[J].中华实用诊断与治疗杂志,2011,25(2):149-152. 被引量:2
  • 10Zhou ZQ, Manguino D, Kewitt K,et al. Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6-methylguanine-DNA methyltransferase [J]. Proc Natl Acad Sci USA, 2001,98(22):12566-12571.

二级参考文献18

  • 1拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 2Cohen O, Feinstein E, Kimchi A. DAP2 kinase is a Ca^2+/ ealmodulin dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity[J]. EMBO J, 1997,16(4) : 998-1008.
  • 3Levy D, Plubureau G, Decroix Y, et al. Death associated protein kinase loss of expression is a new marker for breast cancer prognosis clinical[J]. Cancer Res, 2004, 10 (9) : 3124- 3130.
  • 4Kuester D, Dar A A, Moskaluk C C, et al. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression[J].Neoplasia, 2007,9 (3) :236-245.
  • 5Yamaguchi S, Asao T, Nakamura J, et al. High frequency of DAP kinase gene promoter methylation in colorectal cancer specimens and its identification in serum[J]. Cancer Lett,2003, 194(1):99-105.
  • 6Toyooka S, Toyooka K O, Miyajima K, etal. Epigenetic downregulation of death-associated protein kinase in lung cancer[J]. Clin Cancer Res,2003,9(8):3034-3041.
  • 7Kissil J L, Feinstein E, Cohen O, et al. DAP-kinase loss of expression in various carcinoma and Bcell lymphoma cell lines: possible implications for role as tumor suppressor gene [J]. Oncogene,1997,15(3) :403 -407.
  • 8Eadie J S, Conrad M, Toorchen D, et al. Mechanism of mutagenesis by O6-methylguanine [ J ]. Nature, 1984,308 ( 9 ) : 201-203.
  • 9Matsukura S, Soejima H, Nakagawachi T, et al. CpG methylation of MGMT and hML H1 promoter in hepatocellular carcinoma associated with hepatitis viral infection [J]. Br Cancer,2003,88(4) :521- 529.
  • 10Virmani A K, Muller C, Rathi A, et al. Aberrant methylation during cervical earcinogenesis[J]. Clin Cancer Res, 2001,7 (3) : 584-589.

共引文献14

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部